Bente Lund

20002019
Hvis du har foretaget ændringer i Pure, vil de snart blive vist her.

Publikationer 2000 2019

  • 21 Tidsskriftartikel
  • 15 Konferenceabstrakt i tidsskrift
  • 2 Poster
  • 1 Konferenceartikel i tidsskrift
Filter
Tidsskriftartikel
2019

Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer

PRIMA/ENGOT-OV26/GOG-3012 Investigators, González-Martín, A., Pothuri, B., Vergote, I., DePont Christensen, R., Graybill, W., Mirza, M. R., McCormick, C., Lorusso, D., Hoskins, P., Freyer, G., Baumann, K., Jardon, K., Redondo, A., Moore, R. G., Vulsteke, C., O'Cearbhaill, R. E., Lund, B., Backes, F., Barretina-Ginesta, P. & 11 flere, Haggerty, A. F., Rubio-Pérez, M. J., Shahin, M. S., Mangili, G., Bradley, W. H., Bruchim, I., Sun, K., Malinowska, I. A., Li, Y., Gupta, D. & Monk, B. J., 28 sep. 2019, I : The New England Journal of Medicine.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Ovarian Neoplasms
Disease-Free Survival
Platinum
Homologous Recombination
Placebos
1 Downloads (Pure)

Niraparib Maintenance Therapy in Patients With Recurrent Ovarian Cancer After a Partial Response to the Last Platinum-Based Chemotherapy in the ENGOT-OV16/NOVA Trial

Del Campo, J. M., Matulonis, U. A., Malander, S., Provencher, D., Mahner, S., Follana, P., Waters, J., Berek, J. S., Woie, K., Oza, A. M., Canzler, U., Gil-Martin, M., Lesoin, A., Monk, B. J., Lund, B., Gilbert, L., Wenham, R. M., Benigno, B., Arora, S., Hazard, S. J. & 1 flere, Mirza, M. R., 10 nov. 2019, I : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 37, 32, s. 2968-2973 6 s.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Åben adgang
Fil
Platinum
Ovarian Neoplasms
Drug Therapy
Germ-Line Mutation
Therapeutics
1 Citation (Scopus)

Niraparib plus bevacizumab versus niraparib alone for platinum-sensitive recurrent ovarian cancer (NSGO-AVANOVA2/ENGOT-ov24): a randomised, phase 2, superiority trial

Mirza, M. R., Åvall Lundqvist, E., Birrer, M. J., dePont Christensen, R., Nyvang, G-B., Malander, S., Anttila, M., Werner, T. L., Lund, B., Lindahl, G., Hietanen, S., Peen, U., Dimoula, M., Roed, H., Ør Knudsen, A., Staff, S., Krog Vistisen, A., Bjørge, L., Mäenpää, J. U., AVANOVA investigators & 1 flere, Lund, B., okt. 2019, I : The Lancet. Oncology. 20, 10, s. 1409-1419 11 s.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Platinum
Ovarian Neoplasms
Disease-Free Survival
Drug Therapy
Therapeutics
2018
17 Citationer (Scopus)

Quality of life in patients with recurrent ovarian cancer treated with niraparib versus placebo (ENGOT-OV16/NOVA): results from a double-blind, phase 3, randomised controlled trial

Oza, A. M., Matulonis, U. A., Malander, S., Hudgens, S., Sehouli, J., Del Campo, J. M., Berton-Rigaud, D., Banerjee, S., Scambia, G., Berek, J. S., Lund, B., Tinker, A. V., Hilpert, F., Vázquez, I. P., D'Hondt, V., Benigno, B., Provencher, D., Buscema, J., Agarwal, S. & Mirza, M. R., 2018, I : The Lancet. Oncology. 19, 8, s. 1117-1125 9 s.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Ovarian Neoplasms
Randomized Controlled Trials
Placebos
Quality of Life
Platinum
2016
9 Citationer (Scopus)

Identification of high-risk patients by human epididymis protein 4 levels during follow-up of ovarian cancer

Dahl Steffensen, K., Waldstrøm, M., Brandslund, I., Lund, B., Mejer Sørensen, S., Petzold, M. & Jakobsen, A., 2016, I : Oncology Letters. 11, 6, s. 3967-3974 8 s.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Åben adgang
91 Citationer (Scopus)

Standard first-line chemotherapy with or without nintedanib for advanced ovarian cancer (AGO-OVAR 12): a randomised, double-blind, placebo-controlled phase 3 trial

du Bois, A., Kristensen, G., Ray-Coquard, I., Reuss, A., Pignata, S., Colombo, N., Denison, U., Vergote, I., Del Campo, J. M., Ottevanger, P., Heubner, M., Minarik, T., Sevin, E., de Gregorio, N., Bidziński, M., Pfisterer, J., Malander, S., Hilpert, F., Mirza, M. R., Scambia, G. & 8 flere, Meier, W., Nicoletto, M. O., Bjørge, L., Lortholary, A., Sailer, M. O., Merger, M., Harter, P. & AGO Study Group led Gynecologic Cancer Intergroup/European Network of Gynaecologic Oncology Trials Groups Intergroup Consortium, jan. 2016, I : Lancet Oncology. 17, 1, s. 78-89 12 s.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Ovarian Neoplasms
Placebos
Drug Therapy
Carboplatin
Paclitaxel
2015
238 Citationer (Scopus)
88 Downloads (Pure)

Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial

Oza, A. M., Cook, A. D., Pfisterer, J., Embleton, A., Ledermann, J. A., Pujade-Lauraine, E., Kristensen, G., Carey, M. S., Beale, P., Cervantes, A., Park-Simon, T-W., Rustin, G., Joly, F., Mirza, M. R., Plante, M., Quinn, M. S., Poveda, A., Jayson, G. C., Stark, D., Swart, A. M. & 5 flere, Farrelly, L., Kaplan, R., Parmar, M. K. B., Perren, T. J. & ICON7 trial investigators, aug. 2015, I : Lancet Oncology. 16, 8, s. 928-936 9 s.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Åben adgang
Fil
Ovarian Neoplasms
Drug Therapy
Survival
Disease-Free Survival
Survival Rate
2014
5 Citationer (Scopus)

A multicenter, non-randomized, phase II study of docetaxel and carboplatin administered every 3 weeks as second line chemotherapy in patients with first relapse of platinum sensitive epithelial ovarian, peritoneal or fallopian tube cancer

Wang, Y., Herrstedt, J., Havsteen, H., Christensen, R. D., Mirza, M. R., Lund, B., Maenpaa, J. & Kristensen, G., 2014, I : B M C Cancer. 2014, 14, 937.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Åben adgang

Vellykket behandling af lokal avanceret, småcellet, neuroendokrint cervixkarcinom

Rasmussen, L. B., Lindegaard, J. C., Lund, B., Grove, A. & Fokdal, L. U., 2014, I : Ugeskrift for Laeger. 176, 2 s., V06140374.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

2013
17 Citationer (Scopus)

Panitumumab and pegylated liposomal doxorubicin in platinum-resistant epithelial ovarian cancer with KRAS wild-type: the PaLiDo study, a phase II nonrandomized multicenter study

Steffensen, K. D., Waldstrøm, M., Pallisgård, N., Lund, B., Bergfeldt, K., Wihl, J., Keldsen, N., Marth, C., Vergote, I. & Jakobsen, A., 1 jan. 2013, I : International Journal of Gynecological Cancer. 23, 1, s. 73-80 8 s.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Platinum
Multicenter Studies
Ovarian Neoplasms
Confidence Intervals
Skin
3 Citationer (Scopus)

Primært malignt melanom i vagina

Kahr, H. S., Mejlgaard, E. & Lund, B., 14 jan. 2013, I : Ugeskrift for Laeger. 175, 3, s. 133-4 2 s.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vagina
Melanoma
Pelvic Exenteration
Urethra
Recurrence
2012
28 Citationer (Scopus)

Health-related quality of life in recurrent platinum-sensitive ovarian cancer--results from the CALYPSO trial

Brundage, M., Gropp, M., Mefti, F., Mann, M. K., Lund, B., Gebski, V., Wolfram, G., Reed, N., Pignata, S., Ferrero, A., Brown, J. C., Eisenhauer, E. & Pujade-Lauraine, E., aug. 2012, I : Annals of Oncology. 23, 8, s. 2020-7 8 s.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Carboplatin
Platinum
Ovarian Neoplasms
Quality of Life
Paclitaxel
2011
1134 Citationer (Scopus)

A phase 3 trial of bevacizumab in ovarian cancer

Perren, T. J., Swart, A. M., Pfisterer, J., Ledermann, J. A., Pujade-Lauraine, E., Kristensen, G., Carey, M. S., Beale, P., Cervantes, A., Kurzeder, C., du Bois, A., Sehouli, J., Kimmig, R., Stähle, A., Collinson, F., Essapen, S., Gourley, C., Lortholary, A., Selle, F., Mirza, M. R. & 7 flere, Leminen, A., Plante, M., Stark, D., Qian, W., Parmar, M. K. B., Oza, A. M. & ICON7 Investigators, 29 dec. 2011, I : The New England Journal of Medicine. 365, 26, s. 2484-96 13 s.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Ovarian Neoplasms
Disease-Free Survival
Survival
Disease Progression
Bevacizumab
27 Citationer (Scopus)

Improved Classification of Epithelial Ovarian Cancer: Results of 3 Danish Cohorts

Steffensen, K. D., Waldstrom, M., Grove, A., Lund, B., Pallisgard, N. & Jakobsen, A., 16 sep. 2011, I : International Journal of Gynecological Cancer. 21, s. 1592-1600 9 s.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Mutation
Neoplasms
Survival
Codon
Ovarian epithelial cancer
10 Citationer (Scopus)

Radiobiological impact of reduced margins and treatment technique for prostate cancer in terms of tumor control probability (TCP) and normal tissue complication probability (NTCP)

Jensen, I., Carl, J., Lund, B., Larsen, E. H. & Nielsen, J. N., 2011, I : Medical Dosimetry. 36, s. 130-7 8 s.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Prostatic Neoplasms
Radiotherapy
Conformal Radiotherapy
Neoplasms
Therapeutics
2010
11 Citationer (Scopus)

A phase II study of combination chemotherapy in early relapsed epithelial ovarian cancer using gemcitabine and pegylated liposomal doxorubicin

Mirza, M. R., Lund, B., Lindegaard, J. C., Keldsen, N., Mellemgaard, A., Christensen, R. D. & Bertelsen, K., 1 okt. 2010, I : Gynecologic Oncology. 119, s. 26-31 6 s.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

gemcitabine
Combination Drug Therapy
Drug Therapy
Therapeutics
Ovarian epithelial cancer
2006
3 Citationer (Scopus)
405 Downloads (Pure)

Automated detection of a prostate Ni-Ti stent in electronic portal images.

Carl, J. H., Nielsen, H., Nielsen, J., Lund, B. & Larsen, E. H., 2006, I : Medical Physics. 33, 12, s. 4600-4605 6 s.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Åben adgang
Fil
Stents
Prostate
Radiotherapy
Uncertainty
titanium nickelide
16 Citationer (Scopus)

Feasibility study using a Ni-Ti stent and electronic portal imaging to localize the prostate during radiotherapy.

Carl, J. H., Lund, B., Larsen, E. H. & Nielsen, J., 2006, I : Radiotherapy and Oncology. 78, s. 199-206

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

2005
5 Citationer (Scopus)

Paclitaxel-carboplatin-gemcitabine (TCG) as first-line treatment of ovarian cancer: a prospective multicenter phase II study (AGO-OVAR 8) followed by a prospectively randomized phase III GCIG Intergroup study (AGO-OVAR 9, GINECO-TCG, NSGO-OC-0102) comparing TCG with standard TC

Bois, A. D., Sehouli, J., Lund, B., Joly, E., Huober, J., Jensen, TS., Levy, E., Heilmann, V., Boman, K., Hardy-Bessard, AC., Burges, A., Maenpaa, J., Pujade-Lauraine, E., Pfisterer, J., Gropp, M., Staehle, A., Wimberger, P., Jackisch, C., Schmalfeldt, B., Belau, A. & 5 flere, Loibl, S., Wollschlaeger, K., Canzler, U., Rochon, J. & GINE, GCIG. I. AGO-OVAR. NSGO., 1 nov. 2005, I : International Journal of Gynecological Cancer. 15, Suppl. 3, s. 224-225 2 s.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

26 Citationer (Scopus)

The results of treatment of epithelial ovarian cancer after centralisation of primary surgery. Results from North Jutland, Denmark

Andersen, E. S., Knudsen, A., Svarrer, T., Lund, B., Nielsen, K., Grove, A. & Tetsche, M. S., 2005, I : Gynecologic Oncology. 99, 3, s. 552-556 5 s.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

2001
11 Citationer (Scopus)

Multicenter phase II study of gemcitabine in previously untreated patients with advanced epithelial ovarian cancer

Underhill, CR., Parnis, FX., Highley, MS., Ahern, J., Harper, PG., Hansen, H., Lund, B., Dombernowsky, P., Hirsch, F., Hansen, M., Carmichael, J. & Williams, H. C., 1 sep. 2001, I : Anti-Cancer Drugs. 12, 8, s. 647-652 6 s.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review